Mohid S. Khan

1.4k total citations
47 papers, 1.0k citations indexed

About

Mohid S. Khan is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Mohid S. Khan has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 32 papers in Oncology and 23 papers in Neurology. Recurrent topics in Mohid S. Khan's work include Neuroendocrine Tumor Research Advances (36 papers), Lung Cancer Research Studies (30 papers) and Neuroblastoma Research and Treatments (23 papers). Mohid S. Khan is often cited by papers focused on Neuroendocrine Tumor Research Advances (36 papers), Lung Cancer Research Studies (30 papers) and Neuroblastoma Research and Treatments (23 papers). Mohid S. Khan collaborates with scholars based in United Kingdom, France and United States. Mohid S. Khan's co-authors include Martyn Caplin, Tim Meyer, Christos Toumpanakis, Theodora Tsigani, Tu Vinh Luong, John A. Hartley, Amy A. Kirkwood, Jorge García-Hernández, Kjell Öberg and Jennifer Watkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Mohid S. Khan

42 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohid S. Khan United Kingdom 16 824 799 523 77 72 47 1.0k
Marco Schiavo Lena Italy 14 446 0.5× 315 0.4× 156 0.3× 51 0.7× 131 1.8× 56 548
Vittorio Briganti Italy 11 140 0.2× 187 0.2× 147 0.3× 24 0.3× 59 0.8× 23 406
Domenico Tamburrino Italy 24 1.3k 1.5× 755 0.9× 385 0.7× 123 1.6× 547 7.6× 88 1.5k
Maxime Palazzo France 12 568 0.7× 357 0.4× 150 0.3× 14 0.2× 412 5.7× 36 758
S Garancini Italy 12 227 0.3× 294 0.4× 176 0.3× 48 0.6× 112 1.6× 20 570
J. Le Borgne France 14 635 0.8× 231 0.3× 43 0.1× 36 0.5× 698 9.7× 40 935
Chandra Krishnan United States 12 128 0.2× 48 0.1× 91 0.2× 38 0.5× 162 2.3× 50 523
Hirotaka Arai Japan 16 69 0.1× 438 0.5× 66 0.1× 41 0.5× 476 6.6× 59 928
Martin Barrio United States 9 177 0.2× 176 0.2× 116 0.2× 18 0.2× 63 0.9× 16 449
W.T. Knöfel Germany 7 196 0.2× 93 0.1× 82 0.2× 44 0.6× 169 2.3× 7 395

Countries citing papers authored by Mohid S. Khan

Since Specialization
Citations

This map shows the geographic impact of Mohid S. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohid S. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohid S. Khan more than expected).

Fields of papers citing papers by Mohid S. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohid S. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohid S. Khan. The network helps show where Mohid S. Khan may publish in the future.

Co-authorship network of co-authors of Mohid S. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Mohid S. Khan. A scholar is included among the top collaborators of Mohid S. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohid S. Khan. Mohid S. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haas, Anette, Mohid S. Khan, Azar Kazemi, et al.. (2025). An equivalency and efficiency study for one year digital pathology for clinical routine diagnostics in an accredited tertiary academic center. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(1). 3–12. 3 indexed citations
2.
Khan, Mohid S., Taha Alqahtani, Garima Gupta, et al.. (2025). Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategies. Molecular Cancer. 24(1). 288–288. 3 indexed citations
3.
Khan, Mohid S. & Sandip Hindocha. (2025). In the Nexus of Transformation: Innovations, Challenges and the Future of Digital Oncology. Clinical Oncology. 39. 103763–103763.
4.
Khan, Mohid S., Kathryn Cook, Martin O. Weickert, et al.. (2024). PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK. Supportive Care in Cancer. 32(3). 199–199. 2 indexed citations
5.
6.
Khan, Mohid S., et al.. (2024). Neuroendocrine tumours found at endoscopy: diagnosis and staging. Frontline Gastroenterology. 16(1). 51–58.
7.
Srirajaskanthan, Rajaventhan, John Ramage, Margot Tesselaar, et al.. (2023). Outcomes and survival in patients with advanced intestinal neuroendocrine tumours on home parenteral nutrition, an international multicentre retrospective cohort study. Clinical Nutrition ESPEN. 54. 106–112. 1 indexed citations
8.
Gould, H. J., R. E. Taylor, Katherine L. Cook, et al.. (2022). P286 Earlier diagnosis of neuroendocrine tumours (NETs) through transformation of the South Wales NET service. Poster presentations. A179.1–A179. 1 indexed citations
9.
10.
Khan, Mohid S. & D. Mark Pritchard. (2020). Neuroendocrine tumours: what gastroenterologists need to know. Frontline Gastroenterology. 13(1). 50–56. 11 indexed citations
11.
Bouvier, Catherine, Kwok Wong, Rajaventhan Srirajaskanthan, et al.. (2019). Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015. British Journal of Cancer. 121(11). 966–972. 55 indexed citations
12.
Khan, Mohid S., Amy A. Kirkwood, Theodora Tsigani, et al.. (2015). Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms. Clinical Cancer Research. 22(1). 79–85. 66 indexed citations
13.
Li, Su‐Chen, Mohid S. Khan, Martyn Caplin, et al.. (2015). Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs. PLoS ONE. 10(5). e0125553–e0125553. 34 indexed citations
14.
Giandomenico, Valeria, Irvin M. Modlin, Fredrik Pontén, et al.. (2013). Improving the Diagnosis and Management of Neuroendocrine Tumors: Utilizing New Advances in Biomarker and Molecular Imaging Science. Neuroendocrinology. 98(1). 16–30. 15 indexed citations
15.
Khan, Mohid S. & Martyn Caplin. (2013). The use of biomarkers in neuroendocrine tumours. Frontline Gastroenterology. 4(3). 175–181. 7 indexed citations
16.
Khan, Mohid S., Amy A. Kirkwood, Theodora Tsigani, et al.. (2012). Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors. Journal of Clinical Oncology. 31(3). 365–372. 137 indexed citations
17.
Khan, Mohid S., Theodora Tsigani, Mohammed Rashid, et al.. (2011). Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. Clinical Cancer Research. 17(2). 337–345. 90 indexed citations
18.
Desai, Kalpna, Mohid S. Khan, Christos Toumpanakis, & M. Caplin. (2009). Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).. PubMed. 55(4). 425–43. 5 indexed citations
19.
Khan, Mohid S., et al.. (2004). The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration. BJOG An International Journal of Obstetrics & Gynaecology. 111(5). 468–474. 40 indexed citations
20.
Khan, Mohid S., et al.. (2004). The Increasing Significance of How to Learn Motor Skills. International Journal of Surgery. 2(2). 124–125. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Schiavo Lena Breakdown of academic impact, for papers by Vittorio Briganti Breakdown of academic impact, for papers by Domenico Tamburrino Breakdown of academic impact, for papers by Maxime Palazzo Breakdown of academic impact, for papers by S Garancini Breakdown of academic impact, for papers by J. Le Borgne Breakdown of academic impact, for papers by Chandra Krishnan Breakdown of academic impact, for papers by Hirotaka Arai Breakdown of academic impact, for papers by Martin Barrio Breakdown of academic impact, for papers by W.T. Knöfel
Rankless by CCL
2026